Literature DB >> 28405511

NK cells control breast cancer and related cancer stem cell hematological spread.

Rossana Tallerico1, Laura Conti2, Stefania Lanzardo2, Rosa Sottile3, Cinzia Garofalo1, Arnika K Wagner4, Maria H Johansson4, Costanza Maria Cristiani1, Klas Kärre4, Ennio Carbone3, Federica Cavallo2.   

Abstract

The growth and recurrence of a number of cancers is driven by a scarce population of cancer stem cells (CSCs), which are resistant to most current therapies. It has been shown previously that natural killer (NK) cells recognize human glioma, melanoma, colon and prostate CSCs in vitro. We herein show that human and mouse breast CSCs are also susceptible to NK cytotoxic activity in vitro. Moreover, CSC induced autologous NK cell activation and expansion in vivo, which correlate with the inhibition of CSC metastatic spread. These data suggest that NK cells control CSC metastatic spread in vivo and that their use in breast cancer therapy may well be fruitful.

Entities:  

Keywords:  Breast cancer; CSCs; NK cells; immunotherapy; metastasization; tumorspheres

Year:  2017        PMID: 28405511      PMCID: PMC5384375          DOI: 10.1080/2162402X.2017.1284718

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  44 in total

Review 1.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

2.  Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model.

Authors:  Simonetta Geninatti Crich; Juan Carlos Cutrin; Stefania Lanzardo; Laura Conti; Ferenc K Kálmán; Ibolya Szabó; Néstor R Lago; Achille Iolascon; Silvio Aime
Journal:  Contrast Media Mol Imaging       Date:  2012 May-Jun       Impact factor: 3.161

3.  Cancer risk: role of environment—response.

Authors:  Cristian Tomasetti; Bert Vogelstein
Journal:  Science       Date:  2015-02-05       Impact factor: 47.728

Review 4.  Cancer stem cells: lessons from leukemia.

Authors:  Jean C Y Wang; John E Dick
Journal:  Trends Cell Biol       Date:  2005-09       Impact factor: 20.808

5.  Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice.

Authors:  Marco Macagno; Silvio Bandini; Lorenzo Stramucci; Elena Quaglino; Laura Conti; Elisa Balmas; Mark J Smyth; Pier-Luigi Lollini; Piero Musiani; Guido Forni; Manuela Iezzi; Federica Cavallo
Journal:  J Immunol       Date:  2014-04-30       Impact factor: 5.422

Review 6.  Natural killer cell education and tolerance.

Authors:  Mark T Orr; Lewis L Lanier
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

7.  Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules.

Authors:  Rossana Tallerico; Matilde Todaro; Simone Di Franco; Cristina Maccalli; Cinzia Garofalo; Rosa Sottile; Camillo Palmieri; Luca Tirinato; Pradeepa N Pangigadde; Rosanna La Rocca; Ofer Mandelboim; Giorgio Stassi; Enzo Di Fabrizio; Giorgio Parmiani; Alessandro Moretta; Francesco Dieli; Klas Kärre; Ennio Carbone
Journal:  J Immunol       Date:  2013-01-23       Impact factor: 5.422

8.  Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.

Authors:  Matilde Todaro; Matilde D'Asaro; Nadia Caccamo; Flora Iovino; Maria Giovanna Francipane; Serena Meraviglia; Valentina Orlando; Carmela La Mendola; Gaspare Gulotta; Alfredo Salerno; Francesco Dieli; Giorgio Stassi
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

9.  NK cells recognize and kill human glioblastoma cells with stem cell-like properties.

Authors:  Roberta Castriconi; Antonio Daga; Alessandra Dondero; Gianluigi Zona; Pietro Luigi Poliani; Alice Melotti; Fabrizio Griffero; Daniela Marubbi; Renato Spaziante; Francesca Bellora; Lorenzo Moretta; Alessandro Moretta; Giorgio Corte; Cristina Bottino
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

10.  The noninflammatory role of high mobility group box 1/Toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells.

Authors:  Laura Conti; Stefania Lanzardo; Maddalena Arigoni; Roberta Antonazzo; Enrico Radaelli; Daniela Cantarella; Raffaele A Calogero; Federica Cavallo
Journal:  FASEB J       Date:  2013-08-22       Impact factor: 5.191

View more
  18 in total

1.  Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells.

Authors:  Gaetano Donofrio; Giulia Tebaldi; Stefania Lanzardo; Roberto Ruiu; Elisabetta Bolli; Andrea Ballatore; Valeria Rolih; Francesca Macchi; Laura Conti; Federica Cavallo
Journal:  Oncoimmunology       Date:  2018-09-06       Impact factor: 8.110

2.  Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.

Authors:  Antonino Di Lorenzo; Elisabetta Bolli; Roberto Ruiu; Giuseppe Ferrauto; Enza Di Gregorio; Lidia Avalle; Aurora Savino; Pietro Poggio; Irene Fiore Merighi; Federica Riccardo; Mara Brancaccio; Elena Quaglino; Federica Cavallo; Laura Conti
Journal:  Oncoimmunology       Date:  2022-06-15       Impact factor: 7.723

Review 3.  Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer.

Authors:  Yuedi Zhang; Qiulin Cui; Manman Xu; Duo Liu; Shuzhong Yao; Ming Chen
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 4.  Natural killer cell homing and trafficking in tissues and tumors: from biology to application.

Authors:  Guang He Ran; Yu Qing Lin; Lei Tian; Tao Zhang; Dong Mei Yan; Jian Hua Yu; You Cai Deng
Journal:  Signal Transduct Target Ther       Date:  2022-06-29

Review 5.  Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD.

Authors:  Bruce R Blazar; Geoffrey R Hill; William J Murphy
Journal:  Nat Rev Clin Oncol       Date:  2020-04-20       Impact factor: 66.675

Review 6.  The Role of Innate Immunity in the Pathogenesis of Breast Cancer.

Authors:  Damir Grebić; Tamara Gulić; Alma Starčević; Manuela Alvirović; Gordana Blagojević Zagorac; Petra Valković Zujić; Danijela Veljković Vujaklija
Journal:  Breast Care (Basel)       Date:  2020-05-04       Impact factor: 2.860

7.  Progesterone promotes immunomodulation and tumor development in the murine mammary gland.

Authors:  Lauryn R Werner; Katelin A Gibson; Merit L Goodman; Dominika E Helm; Katherine R Walter; Sean M Holloran; Gloria M Trinca; Richard C Hastings; Howard H Yang; Ying Hu; Junping Wei; Gangjun Lei; Xiao-Yi Yang; Rashna Madan; Alfredo A Molinolo; Mary A Markiewicz; Prabhakar Chalise; Margaret L Axelrod; Justin M Balko; Kent W Hunter; Zachary C Hartman; Carol A Lange; Christy R Hagan
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

Review 8.  Could Harnessing Natural Killer Cell Activity Be a Promising Therapy for Prostate Cancer?

Authors:  Jennifer Wu
Journal:  Crit Rev Immunol       Date:  2021       Impact factor: 2.214

9.  A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo.

Authors:  Elisabetta Bolli; John P O'Rourke; Laura Conti; Stefania Lanzardo; Valeria Rolih; Jayne M Christen; Giuseppina Barutello; Marco Forni; Federica Pericle; Federica Cavallo
Journal:  Oncoimmunology       Date:  2017-12-06       Impact factor: 8.110

10.  Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing.

Authors:  Benjamin Wolfson; Michelle R Padget; Jeffrey Schlom; James W Hodge
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.